Molecular Pharmaceutics p. 3979 - 3996 (2018)
Update date:2022-08-28
Topics:
Pei, Zhonghua
Chen, Chunjiao
Chen, Jinhua
Cruz-Chuh, Josefa Dela
Delarosa, Reginald
Deng, Yuzhong
Fourie-O'Donohue, Aimee
Figueroa, Isabel
Guo, Jun
Jin, Weiwei
Khojasteh, S. Cyrus
Kozak, Katherine R.
Latifi, Brandon
Lee, James
Li, Guangmin
Lin, Eva
Liu, Liling
Lu, Jiawei
Martin, Scott
Ng, Carl
Nguyen, Trung
Ohri, Rachana
Lewis Phillips, Gail
Pillow, Thomas H.
Rowntree, Rebecca K.
Stagg, Nicola J.
Stokoe, David
Ulufatu, Sheila
Verma, Vishal A.
Wai, John
Wang, Jing
Xu, Keyang
Xu, Zijin
Yao, Hui
Yu, Shang-Fan
Zhang, Donglu
Dragovich, Peter S.
A number of cytotoxic pyrrolobenzodiazepine (PBD) monomers containing various disulfide-based prodrugs were evaluated for their ability to undergo activation (disulfide cleavage) in vitro in the presence of either glutathione (GSH) or cysteine (Cys). A good correlation was observed between in vitro GSH stability and in vitro cytotoxicity toward tumor cell lines. The prodrug-containing compounds were typically more potent against cells with relatively high intracellular GSH levels (e.g., KPL-4 cells). Several antibody-drug conjugates (ADCs) were subsequently constructed from PBD dimers that incorporated selected disulfide-based prodrugs. Such HER2 conjugates exhibited potent antiproliferation activity against KPL-4 cells in vitro in an antigen-dependent manner. However, the disulfide prodrugs contained in the majority of such entities were surprisingly unstable toward whole blood from various species. One HER2-targeting conjugate that contained a thiophenol-derived disulfide prodrug was an exception to this stability trend. It exhibited potent activity in a KPL-4 in vivo efficacy model that was approximately three-fold weaker than that displayed by the corresponding parent ADC. The same prodrug-containing conjugate demonstrated a three-fold improvement in mouse tolerability properties in vivo relative to the parent ADC, which did not contain the prodrug.
View MoreNINGBO PANGS CHEM INT’L CO., LTD.
Contact:+86-0574-27666801
Address:Floor 21, Building 11, Xintiandi, No. 689, Shijiroad, Ningbo, Zhejiang, China
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Shanghai Witshoot Internet Technology Co Ltd
Contact:+86-21-66390020
Address:Room 419, No.285 Luochuan Road (E)
Daqing New Century Fine Chemical Co., Ltd.
Contact:010-57126694
Address:No.39, jinxing cun, honggang district
Jinan Hongfangde Pharmatech Co.LTD
Contact:0531-88870908
Address:F Bldg,750#,Shunhua Rd,New&High-tech Zone,Jinan,Shandong,China 250101
Doi:10.1016/0040-4039(96)00402-9
(1996)Doi:10.1039/b703750c
(2007)Doi:10.1021/jo961715g
(1997)Doi:10.1016/j.molstruc.2008.03.052
(2008)Doi:10.1039/c2ra20650a
(2012)Doi:10.1002/psc.2702
(2014)